Generics
CivicaScript launches droxidopa for symptomatic neurogenic orthostatic hypotension
11 April 2025 - CivicaScript LLC, a nonprofit focused on bringing low-cost generic medicines to US patients, announced on Thursday that it has launched its droxidopa in the United States.Droxidopa is ...
Padagis' Naloxone HCl Nasal Spray 4 mg obtains extended shelf-life of 36 months
3 April 2025 - US-based generic pharmaceutical manufacturer and supplier Padagis announced on Wednesday that the company's over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg has obtained an ext...
ANI Pharmaceuticals announces US launch of Nitazoxanide Tablets
19 March 2025 - Biopharmaceutical company ANI Pharmaceuticals Inc (Nasdaq:ANIP) announced on Wednesday the launch of its Nitazoxanide Tablets, 500 mg, the generic version of the reference listed drug ...
Newbury Pharmaceuticals secures approval for Macitentan in Denmark
14 March 2025 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Friday that it has received marketing authorisation for Macitentan Newbury in Denmark.This is the fi...
Mallinckrodt and Endo to merge in USD6.7bn deal to create pharmaceutical leader
13 March 2025 - Pharmaceutical companies Mallinckrodt plc and Endo Inc (OTCQX:NDOI) announced on Thursday that they have entered into a definitive agreement to merge in a stock and cash transaction, f...
Genomma Lab Internacional announces quarterly dividend
7 March 2025 - Genomma Lab Internacional, SAB de CV (BMV: LABB), a Mexico-based over-the-counter pharmaceutical, generic drugs and personal care products company, announced on Thursday a cash dividend...